Klobetazol Belupo

Clobetasol propionate, the active ingredient in Klobetazol, is a high‑potency topical corticosteroid presented as a cream/ointment formulation for external skin use. It reduces inflammation, redness, scaling and itching associated with chronic dermatoses such as psoriasis, eczema, dermatitis and lichen planus in adult patients.

GNH USA supplies Klobetazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. All batches are manufactured under GMP conditions and undergo rigorous testing before release.

Clobetasol propionate is a potent topical corticosteroid used to manage inflammatory skin conditions. It is commonly prescribed for short‑term control of these conditions.

- Psoriasis: reduces plaque thickness, scaling, redness and associated itching, improving skin appearance. - Eczema: alleviates itching, inflammation and skin irritation, helping restore barrier function. - Dermatitis: controls redness, swelling and discomfort, promoting faster healing of affected areas. - Lichen planus: diminishes lesions and associated itching, reducing chronic inflammation. - Atopic dermatitis: reduces flare severity and itching, supporting skin recovery.

Topical clobetasol propionate may cause local and systemic adverse reactions, most of which are related to its corticosteroid activity.

Common Side Effects: - Skin irritation or burning sensation. - Dryness or peeling of the treated area. - Redness or mild erythema. - Pruritus (itching) at the application site. - Folliculitis or acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Hypopigmentation or depigmentation of the skin. - Secondary infection (bacterial, fungal or viral). - Systemic corticosteroid effects such as adrenal suppression. - Allergic contact dermatitis.

When using clobetasol propionate, several precautions should be observed to minimize risks and ensure safe therapy. - Apply only to intact skin: avoid broken or infected areas. - Limit treatment duration: use for the shortest period necessary, typically up to 2 weeks. - Avoid occlusion: do not cover treated skin with dressings unless directed by a physician. - Do not use on large body surface areas: restrict to affected sites to reduce systemic absorption. - Monitor for signs of adrenal suppression: report unusual fatigue, weakness or hypotension. - Store at room temperature: keep in the original container, protect from moisture and light.

Clobetasol propionate can interact with other medications, altering its absorption or enhancing systemic corticosteroid effects.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects may increase risk of adrenal suppression. - Antifungal agents (e.g., ketoconazole): inhibit metabolism and raise local drug levels, raising irritation risk. - Immunosuppressants (e.g., cyclosporine): may enhance immunosuppressive action, increasing infection susceptibility.

Moderate Interactions (Monitor Closely): - Vaccines (live attenuated): topical steroids may diminish immune response to vaccination. - Photosensitizing drugs (e.g., tetracyclines): combined use may increase risk of photosensitivity reactions. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): concurrent use may heighten risk of systemic side effects if absorption occurs.